Trials / Sponsors / K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia (AML) | Phase 1 / Phase 2 | 2022-12-01 |
| Completed | Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis Amyloidosis, AL Amyloidosis | Phase 1 / Phase 2 | 2021-11-30 |
| Completed | A Food Effect Study of ZN-d5 in Healthy Female Volunteers Healthy Volunteers | Phase 1 | 2021-06-13 |
| Completed | Phase 1 First in Human Study of ZN-d5 as a Single Agent Acute Myeloid Leukemia, Non Hodgkin Lymphoma | Phase 1 | 2020-10-13 |